Danaher (DHR) Net Income towards Common Stockholders (2009 - 2026)
Danaher (DHR) recorded quarterly Net Income towards Common Stockholders of $1.0 billion in Q1 2026, down 13.02% quarter-over-quarter from $1.2 billion in Q4 2025, and up 7.86% on a YoY basis from $954.0 million in Q1 2025.
Danaher (DHR) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Danaher's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $1.0 billion for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 7.86% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $3.7 billion (down 2.39% YoY), while the FY2025 annual figure was $3.6 billion, down 7.31% from the prior year.
- Net Income towards Common Stockholders was $1.0 billion for Q1 2026 at Danaher, down from $1.2 billion in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $2.2 billion in Q4 2022 to a low of $555.0 million in Q2 2025.
- Historically, Net Income towards Common Stockholders has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2024.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders surged 38.85% in 2022, then tumbled 51.18% in 2023.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $2.2 billion in 2022, then sank by 51.18% to $1.1 billion in 2023, then gained by 0.65% to $1.1 billion in 2024, then gained by 8.93% to $1.2 billion in 2025, then fell by 13.02% to $1.0 billion in 2026.
- The last three Net Income towards Common Stockholders figures came in at $1.0 billion (Q1 2026), $1.2 billion (Q4 2025), and $908.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 141.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | -40.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 27, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.18 Bn |
| Sep 26, 2025 | 908.00 Mn |
| Jun 27, 2025 | 555.00 Mn |
| Mar 28, 2025 | 954.00 Mn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 27, 2024 | 818.00 Mn |
| Jun 28, 2024 | 907.00 Mn |
| Mar 29, 2024 | 1.09 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Sep 29, 2023 | 1.13 Bn |
| Jun 30, 2023 | 1.11 Bn |
| Mar 31, 2023 | 1.43 Bn |
| Dec 31, 2022 | 2.21 Bn |
| Sep 30, 2022 | 1.55 Bn |
| Jul 1, 2022 | 1.66 Bn |
| Apr 1, 2022 | 1.68 Bn |
| Dec 31, 2021 | 1.75 Bn |
| Oct 1, 2021 | 1.12 Bn |
| Jul 2, 2021 | 1.74 Bn |